Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Syndax Pharmaceuticals (SNDX) Capital Expenditures: 2014-2021

Historic Capital Expenditures for Syndax Pharmaceuticals (SNDX) over the last 6 years, with Dec 2021 value amounting to $129,000.

  • Syndax Pharmaceuticals' Capital Expenditures fell 66.67% to $14,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $230,000, marking a year-over-year increase of 34.50%. This contributed to the annual value of $129,000 for FY2021, which is N/A change from last year.
  • Per Syndax Pharmaceuticals' latest filing, its Capital Expenditures stood at $129,000 for FY2021, which was down 31.02% from $187,000 recorded in FY2018.
  • In the past 5 years, Syndax Pharmaceuticals' Capital Expenditures registered a high of $187,000 during FY2018, and its lowest value of $84,000 during FY2017.
  • For the 1-year period, Syndax Pharmaceuticals' Capital Expenditures averaged around $129,000, with its median value being $129,000 (2021).
  • Per our database at Business Quant, Syndax Pharmaceuticals' Capital Expenditures crashed by 67.82% in 2017 and then surged by 122.62% in 2018.
  • Syndax Pharmaceuticals' Capital Expenditures (Yearly) stood at $84,000 in 2017, then spiked by 122.62% to $187,000 in 2018, then reached $129,000 in 2021.